Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We are pleased to announce that Prof Joel Tarning has been awarded the biennial Grahame-Smith Prize by the British Pharmacological Society for outstanding contributions to clinical pharmacology. Joel has headed MORU's Clinical Pharmacology Department since 2012. Since then, the Department has grown into large, productive group that conducts laboratory- and computer-based pharmacology research.

Profesor Joel Tarning in a laboratory. © 2020 MORU. Photographer: Gerhard Jørén

Prof David Grahame-Smith, after whom the award Joel was honoured with is named, was Professor of Pharmacology at Oxford for several decades,” said Prof Nick Day, MORU Director. “He taught me as a medical student, and both Nick White and I both worked for him as junior doctors. He was a wonderful man, very funny and deeply humane in his clinical practice. It is very fitting that Joel has won an award associated with such a giant in the field.”

Joel's research interests include infectious disease pharmacology and the use of novel pharmacometric methodologies to identify and optimise the dose in particularly vulnerable populations, such as children and pregnant women. His work on the pharmacokinetic and pharmacodynamic properties of antimalarial drugs in young children with uncomplicated and severe malaria has already had a global impact, resulting in revised WHO Guidelines for the treatment of malaria. 

"David Grahame-Smith was a wonderful man," said Prof Sir Nick White. "Nick Day and I both worked for him. He was cheerful, positive, amusing and down to earth as well as being a world leading clinical pharmacologist and a very good physician. He was also an excellent jazz pianist. It is really nice for Joel to have deservedly won this award and, in doing so, to revive his memory."

As part of his award, Joel has been invited to give a prize lecture at a future, physical meeting of the Society. Please join us in extending your congratulations to Joel.

- Text by John Bleho

Similar stories

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Peter Macharia wins RSTMH Emerging Leader Award

Peter Macharia is a spatial epidemiologist and a postdoc interested in disease mapping, healthcare access and mapping population vulnerabilities at KEMRI Wellcome. He received the RSTMH 2021 Emerging Leader Award, which recognises significant contributions in leadership, mentoring and capacity building in those who are early in their careers.

Lack of evidence is key barrier to using portable devices to detect poor quality medicines

A series of papers which reviewed portable devices to detect poor quality medicines has concluded major gaps in scientific evidence remain a key barrier for regulators to implement surveillance systems using such devices.

RECOVERY Trial paper on dexamethasone wins BMJ’s 2021 UK Research Paper of the Year Award

A RECOVERY Collaborative Group paper has been announced as the 2021 winner of The British Medical Journal’s prestigious UK Research Paper of the Year Award. This award recognises original UK research that has the potential to contribute significantly to improving health and healthcare. The paper, “Dexamethasone in Hospitalized Patients with Covid-19”, published in the New England Journal of Medicine, described the discovery in June 2020 of the world’s first effective, readily available treatment for COVID-19 – the inexpensive steroid, dexamethasone.

Tropical Medicine DPhil Students awarded NDM Prize

Every year, the Nuffield Department of Medicine awards NDM Prizes to our most outstanding students. This year, Mo yin and Rebecca Inglis (both at MORU) were highly commended in the category NDM Overall Prize, for conducting research with an outstanding impact. Will Schilling (MORU) received a prize as first year DPhil student, and Mohammad Ali (OCGHR) as second year DPhil student. Our warmest congratulations to you all!

New study alerts to the risk of poor quality medicines used to prevent and treat cardiovascular disease

There are important but neglected issues with substandard and falsified medicines and medical products used to prevent and treat cardiovascular diseases. From limited available data, MORU and IDDO scientists found about one fifth of medicines reported as sampled in the literature were substandard or falsified. This systematic review suggests that more and better quality data and data sharing are needed to better understand the global burden of this problem and inform interventions.